Lyme disease vaccine: Major test underway. All you need to knowAfter 20 years, there is a possibility that a vaccine against Lyme disease may be ready. People are being tested for its efficacy in both E...
Pfizer to buy 8.1% stake in French vaccines company ValnevaValneva will use the proceeds from Pfizer's equity investment to support its Phase 3 development contribution to the Lyme disease program. ...
European shares slide as weak China data stokes recession woesChina's April retail sales plunged 11.1%, almost twice the fall forecast, while industrial output dropped 2.9% when analysts had looked for...
Covid-19 vaccine: Britain gives first European approval to Valneva shotThe go-ahead is the sixth COVID vaccine approval by Britain and comes even though London last September scrapped a 1.4 billion euro ($1.5 b...
Britain approves Moderna's COVID shot for children aged six and olderThe Medicines and Healthcare products Regulatory Agency (MHRA) said the approval was granted after Moderna's vaccine, known as Spikevax, me...
UK approves Valneva's Covid-19 vaccine"An approval has been granted after the Valneva Covid-19 vaccine was found to meet the required safety, quality and effectiveness standards...
European shares track global markets higher on Ukraine summit optimismEuropean auto stocks were in the lead, gaining 1.3% after French car parts group Faurecia forecast a rise in annual sales, as it expects se...
EU regulator set to rule on Pfizer COVID pill by end-Jan, ahead of Merck - sourceThe EMA's review of Merck's pill, developed with Ridgeback Biotherapeutics, is taking longer than Pfizer's because Merck released trial dat...
Can Covid vaccines work as boosters? Here's what researches have to sayIf boosters don’t work well against the variant, vaccine developers will need to make new shots.
Booster dose of six Covid vaccines safe, increases immunity: Lancet studyProtection against COVID-19 infection wanes over time, which has driven consideration of boosters to protect the most vulnerable and lessen...
EU drug regulator starts reviewing new coronavirus vaccineA rolling review is an accelerated way of assessing new drugs that allows European Medicine Agency experts to look at data from ongoing stu...
Oil, banks lift European stocks on recovery betsThe pan-European STOXX 600 index was up 0.4% after hitting a three-week low last week. Asian stocks, however, fell following news of fresh ...
UK begins 'booster' shot trial of 7 different COVID-19 vaccinesBritain launched a nationwide study on Wednesday to explore whether giving a third dose "booster" shot of coronavirus vaccines would be saf...
New COVID vaccine shows 'strong immune response' in early UK trialsUK Health Secretary Matt Hancock said that the promising Phase I and II results mean that the Valneva vaccine, being developed at Livingsto...
EU regulator is considering Oxford-AstraZeneca vaccineThe EU regulator said it received a request for the vaccine to be green-lighted under an expedited process and that it could be approved by...
EU seeks more Moderna COVID-19 vaccines, eyes deals with Valneva, NovavaxThe bloc, with a population of nearly 450 million, has already booked a total of almost 2.3 billion doses from six vaccine makers. Most vac...
Britain secures 90 million possible COVID-19 vaccine doses from Pfizer/BioNTech, ValnevaWith no working vaccine against COVID-19 yet developed, Britain now has three different types of vaccine under order and a total of 230 mil...